Proteases as Targets for Therapy by Klaus, von der HelmProteases as Targets for Therapy by Klaus, von der Helm

Proteases as Targets for Therapy

EditorKlaus, von der Helm, BRUCE Korant, John C. Cheronis

Paperback | October 10, 2012

Pricing and Purchase Info

$150.34 online 
$167.95 list price save 10%
Earn 752 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

This volume is the first to combine latest information on viral, microbial and cellular proteolytic enzymes as potential targets for human therapeutics. Proteases control a large array of physiological reactions, and are involved in a variety of pathological processes for which effective medications are currently needed and/or being sought after. Although protease inhibitors have been investigated for many years, few have been employed therapeutically. Recent break- through by HIV protease inhibitors as therapeutic drugs has re-encouraged the search for inhibitors of other proteolytic enzymes. Klaus von der Helm, who described the first viral protease has brought leading experts together to discuss not only the success and problems of clinical use and continuing prospects, but to review further potential drug targets. This volume provides detailed information and evaluations of key viral, bacterial, fungal, and cellular proteases as potential future drug candidates.
Title:Proteases as Targets for TherapyFormat:PaperbackDimensions:438 pages, 9.25 × 6.1 × 0.68 inPublished:October 10, 2012Publisher:Springer Berlin HeidelbergLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3642630235

ISBN - 13:9783642630231

Look for similar items by category:

Customer Reviews of Proteases as Targets for Therapy

Reviews

Table of Contents

I: HIV Protease Inhibitors (PI).- II: Other Viral (Non-HIV) Protease Inhibitors.- III: (Non-Viral) Proteases Involved in Diseases.